Rendo, Jaida .
HRN: 19-38-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 500MG (TAB)
10/25/2024
11/01/2024
ORAL
500mg
BID
S/P LSTCS
Waiting Final Action